COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R) : MDxHealth conclut un partenariat avec LifeLabs pour commercialiser SelectMDx au Canada
14/02/2019
COMMUNIQUÉ DE PRESSE IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CET, 14 février 2019 - MDxHealth SA (Euronext : MDXH.BR) annonce aujourd'hui qu'elle a signé un accord de distribution exclusive avec LifeLabs pour [...]
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
14/02/2019
CHICAGO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Caladrius Biosciences Reports Top-Line Data for the Phase 2a Sanford Project: T-Rex Trial of CLBS03 for Recent Onset Type 1 Diabetes
13/02/2019
BASKING RIDGE, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with multiple development [...]
Mesoblast Financial Results Webcast for Half Year, Q2 Ended December 31, 2018
13/02/2019
NEW YORK and MELBOURNE, Australia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) will report financial results for the half year and second quarter ended December 31, 2018 in a webcast [...]
National Research Corporation Declares Quarterly Dividend
13/02/2019
Lincoln, Nebraska, Feb. 13, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 (nineteen cents) per share [...]
BeiGene to Hold Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019 and Host Investor Event in Hong Kong
13/02/2019
CAMBRIDGE, Mass., and BEIJING, China, Feb. 13, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease
13/02/2019
Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO Fascioliasis, commonly known as liver fluke infestation, is estimated [...]
EyePoint Pharmaceuticals Secures Up to $60 Million Debt Facility
13/02/2019
– Provides support for the product launches of YUTIQ™ and DEXYCU™ – WATERTOWN, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to [...]
Adverum to Present at the 8th Annual SVB Leerink Global Healthcare Conference
13/02/2019
MENLO PARK, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the [...]
Akcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast
13/02/2019
Webcast scheduled for Tuesday, February 26th at 4:30 p.m. Eastern Time BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that [...]
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019
13/02/2019
BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK ), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018
13/02/2019
PORTLAND, Maine, Feb. 13, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) - a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
AIT Therapeutics Reports Financial Results for Fiscal Third Quarter 2019
13/02/2019
Announced transformational partnership agreement with Circassia Pharmaceuticals PMA filing for treatment of PPHN on track for second quarter calendar 2019 Completed treatment safely of a compassionate use NTM patient at [...]
Myriad Genetics to Present at Multiple Upcoming Healthcare Conferences
13/02/2019
SALT LAKE CITY, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced that it will be presenting at multiple upcoming healthcare [...]
DBV Technologies Provides Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children 4 to 11 Years of Age
13/02/2019
Montrouge, France, February 13, 2019 DBV Technologies Provides Update on Regulatory Status of Viaskin Peanut for the Treatment of Peanut-Allergic Children 4 to 11 Years of Age Progress made to date to enable BLA [...]
DBV Technologies fait le point sur le parcours réglementaire de Viaskin Peanut pour le traitement des enfants âgés de 4 à 11 ans allergiques à l’arachide
13/02/2019
Montrouge, France, le 13 février (22 : 00 CET) 2019 DBV Technologies fait le point sur le parcours réglementaire de Viaskin Peanut pour le traitement des enfants âgés de 4 à 11 ans allergiques à l’arachide Des progrès [...]
Canopy Rivers to Report Third Quarter Fiscal 2019 Financial Results
13/02/2019
TORONTO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ”) (TSXV: RIV) will report its third quarter fiscal 2019 financial results after markets close on Wednesday February 27, 2019. The Company’s [...]
ICC Hemp Acquisitions Bolsters European Supply Chain, Speeds Extraction -- CFN Media
13/02/2019
SEATTLE, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Media Statement from Amedisys Commending the Home Health Payment Innovation Act
13/02/2019
BATON ROUGE, La., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, commends bipartisan legislation to preserve and expand [...]

Pages